Ellipsys Medical, Inc.
About Ellipsys Medical, Inc.
Ellipsys Medical, Inc. is dedicated to advancing vascular access technologies that improve patient outcomes in end-stage renal disease. The company partners with clinicians and health systems to deliver solutions that enhance care quality, streamline workflows, and support long-term access durability. Its Ellipsys Vascular Access System enables physicians to create a percutaneous AV fistula using a single catheter under ultrasound guidance.
- 🔗 Avenu Medical pulls in $6m for Ellipsys AV fistula device - MassDevice
- 🔗 Ellipsys Vascular Access System to Return to U.S. Market in 2026
- 🔗 Ellipsis Health raises $45M for empathetic #AIvoice agent, Sage | Jesse Landry posted on the topic | LinkedIn
- 🔗 Ellipsys 2026 Company Profile: Valuation, Investors, Acquisition | PitchBook
- 🔗 Avenu Medical, 27123 Calle Arroyo, San Juan Capistrano, CA 92675-6785, US - MapQuest
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $5.9M in private placement from 46 anonymous investors.
- Ellipsys system creates percutaneous AV fistulas for hemodialysis under ultrasound guidance.
- Product previously associated with Avenu Medical and slated for U.S. market return in 2026.
Ask StreetZero about Ellipsys Medical, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account